PhRMA Statement on Medicare Part D Coverage Gap
Pharmaceutical Research and Manufacturers of America President and CEO Billy Tauzin and PhRMA Board Chairman David Brennan, Chief Executive Officer, AstraZeneca, issued the following statement regarding commitment, as part of health care reform, to help close the coverage gap in the Medicare prescription drug program: "PhRMA is committed to working with the Administration and Congress to help enact comprehensive health care reform this year. We share a common goal: every American should have access to affordable, high-quality health care coverage and services. [more...]
|
|
|
